Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
<p>Abstract</p> <p>Background</p> <p>Self-administration of recombinant human follicle-stimulating hormone (r-hFSH) can be performed using injection pen devices by women undergoing assisted reproductive technology procedures. The objective of this study was to explore t...
Main Authors: | Welcker J, Nawroth Frank, Bilger Wilma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-09-01
|
Series: | Reproductive Biology and Endocrinology |
Online Access: | http://www.rbej.com/content/8/1/111 |
Similar Items
-
Managing infertility with the follitropin alfa prefilled pen injector – patient considerations
by: Bühler K
Published: (2015-06-01) -
Aktuelles: Neuer Follitropin-alfa-Pen getestet
Published: (2011-01-01) -
Aktuelles: Neuer Follitropin-alfa-Pen getestet
Published: (2011-01-01) -
Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction
by: Nawroth F, et al.
Published: (2015-04-01) -
Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment
by: Illingworth PJ, et al.
Published: (2014-06-01)